CANDOR – Cancer Detection by Odor

Description

Cancer is a global health problem and a leading cause of death. Early detection of cancer, combined with effective treatments, will significantly improve patient survival. Established cancer diagnostics based on biopsies, Imaging and blood tests, while important and effective, have their limitations, are invasive, time-consuming, costly and sometimes painful. The CANDOR pilot study aims to explore the diagnostic capability of sensor-based techniques for the non-invasive early detection of cancer by analyzing volatile organic compounds (VOCs), which reportedly have been associated with certain malignancies. Novel sensor technology in conjunction with AI-based pattern analysis aims to identify odor signatures that discriminate tumor tissue from non-malignant human tissue. Moreover, we will investigate of the suitability of different cancer types, as well as the dependency on tumor burden and location. The results of this research project may expand the existing diagnostic armamentarium, and will also
create a basis for future projects exploring olfactory technology in cancer diagnosis and treatment guidance. They might pave the road for the development of innovative diagnostic tools in other clinical disciplines beyond cancer.

Period	10 Apr 2025
Event title	Forschungsinteraktion TNF - MED 2025
Event type	Conference
Location	Linz, AustriaShow on map
Degree of Recognition	Local